ELSEVIER
Contents lists available at ScienceDirect
Biomedicine & Pharmacotherapy
journal homepage: www.elsevier.com/locate/biopha
biomedicine AND. PHARMACOTHERAPY
Corrigendum
Corrigendum to “FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma” [Biomed. Pharmacother. 192 (2025) 118677]
Check for updates
Sara Taranto a,b,1, Jessica Faletti ª,1, Mariangela Tamburello ª, Roberto Ronca a,c, Giulia Garattini ª, Giorgia Gazzaroli ª, Marta Turati ª, Edoardo Rocca ª, Riccardo Castelli d, Andrea Abate ª, Luca Mignaniª, Marta Laganà e, Constanze Hantel f,8, Sandra Sigala ª, Marco Presta ª, Arianna Giacomini a,’
a Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
b Clinical Trial Center, Translational Research and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy
” Consorzio Interuniversitario per le Biotecnologie (CIB), Italy
d Department of Food and Drug, University of Parma, Parma, Italy
e Medical Oncology Department, ASST Spedali Civili of Brescia, Brescia, Italy
Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zürich, Switzerland
8 Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
| The author regrets that there are typos in the article title and it needs | To: |
|---|---|
| to be corrected as provided below. | FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper |
| From: | the growth of adrenocortical carcinoma. |
| FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and ham- pers the growth of adrenocortical carcinoma. | The title presented in this corrigendum is the final and correct one. The authors would like to apologise for any inconvenience caused. |
DOI of original article: https://doi.org/10.1016/j.biopha.2025.118677.
* Corresponding author. E-mail address: arianna.giacomini@unibs.it (A. Giacomini).
1 Co-first authors.